drugset / Trial / NCT01327144

Efficacy of Oral Famciclovir Versus Aciclovir Treatment in Patients With Herpes Zoster

NCT01327144 ↗

Phase 3 Completed 177 enrolled EMS
RandomizedParallel-groupSingle-blindTreatment

Summary

Herpes Zoster is an infection that affects part of the nervous system caused by Varicella Zoster Virus. Herpes Zoster manifests as vesicular eruption in the dermatome, often associated with significant pain. There are effective oral prescription antiviral medicines available to reduce the discomfort of symptoms as famciclovir and aciclovir. This is a phase III, multicenter, randomized, parallel-group study to compare the efficacy and safety of treatment with Famciclovir (500 mg) comparing to Aciclovir (400 mg) in patients with Herpes Zoster.

Timeline

Start
2012-06
Primary completion
2017-05
Completion
2017-07

Outcome

Met primary endpoint

paper Analysis of the primary efficacy endpoint proved that famciclovir is non-inferior to acyclovir PMID 29746903 ↗

Drugs

EvaluationDrugModalityDoseRoute
Comparator Acyclovir Small molecule 400 mg Oral
Subject Famciclovir Small molecule 500 mg Oral

Indications